Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
GLOBAL RESEARCH TRENDS IN FLORFENICOL: A FOUR-DECADE BIBLIOMETRIC ANALYSIS OF SCIENTIFIC EVOLUTION FROM VETERINARY THERAPEUTICS TO ENVIRONMENTAL AND RESISTANCE CONCERNS
View through CrossRef
Florfenicol, a broad-spectrum antibiotic extensively used in veterinary medicine, has gained significant attention in recent research because of growing concerns about antimicrobial resistance and its environmental impacts, particularly within the context of the One Health approach. A comprehensive bibliometric analysis of 972 florfenicol publications indexed in Scopus (1986-2025) was conducted using Bibliometrix R package and VOSviewer. Multiple indicators were assessed including annual production trends, journal distribution, author productivity, institutional affiliations, international collaborations, citation patterns, and thematic evolution through keyword analysis. Florfenicol research demonstrated remarkable growth with a 10.55% annual increase, evolving through four distinct phases from minimal activity (1986-1999) to exponential expansion (2018-2025). China dominated with 401 corresponding author publications (41.3%), followed by the USA (84 articles, 8.6%). Strong international collaboration was observed (17.6% multi-country publications), particularly between China and the USA (32 joint studies). Thematic evolution shifted from basic pharmacokinetics and residue studies to contemporary focus on antimicrobial resistance genes, impact on the environment, and advanced analytical methods. Highly cited studies emphasized resistance mechanisms and environmental dissemination. Florfenicol research has transformed from a niche veterinary topic into a multidisciplinary domain addressing global antimicrobial resistance challenges. The field demonstrates strong international collaboration but reveals geographic disparities requiring attention. Future research should prioritize prevention strategies over detection methods while establishing networks linking high-output countries with underrepresented regions for comprehensive global resistance surveillance.
Scientific Veterinary Institute 'Novi Sad'
Title: GLOBAL RESEARCH TRENDS IN FLORFENICOL: A FOUR-DECADE BIBLIOMETRIC ANALYSIS OF SCIENTIFIC EVOLUTION FROM VETERINARY THERAPEUTICS TO ENVIRONMENTAL AND RESISTANCE CONCERNS
Description:
Florfenicol, a broad-spectrum antibiotic extensively used in veterinary medicine, has gained significant attention in recent research because of growing concerns about antimicrobial resistance and its environmental impacts, particularly within the context of the One Health approach.
A comprehensive bibliometric analysis of 972 florfenicol publications indexed in Scopus (1986-2025) was conducted using Bibliometrix R package and VOSviewer.
Multiple indicators were assessed including annual production trends, journal distribution, author productivity, institutional affiliations, international collaborations, citation patterns, and thematic evolution through keyword analysis.
Florfenicol research demonstrated remarkable growth with a 10.
55% annual increase, evolving through four distinct phases from minimal activity (1986-1999) to exponential expansion (2018-2025).
China dominated with 401 corresponding author publications (41.
3%), followed by the USA (84 articles, 8.
6%).
Strong international collaboration was observed (17.
6% multi-country publications), particularly between China and the USA (32 joint studies).
Thematic evolution shifted from basic pharmacokinetics and residue studies to contemporary focus on antimicrobial resistance genes, impact on the environment, and advanced analytical methods.
Highly cited studies emphasized resistance mechanisms and environmental dissemination.
Florfenicol research has transformed from a niche veterinary topic into a multidisciplinary domain addressing global antimicrobial resistance challenges.
The field demonstrates strong international collaboration but reveals geographic disparities requiring attention.
Future research should prioritize prevention strategies over detection methods while establishing networks linking high-output countries with underrepresented regions for comprehensive global resistance surveillance.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
Abstract
Background
Given the increasing prevalence of non-albicans Candida species, including C. glabrata and C. auris, which h...
Chloramphenicol and Analogues
Chloramphenicol and Analogues
AbstractChloramphenicol, C11H12Cl2N2O5, is a commercially significant antibacterial agent. Although widespread use of this antibiotic declined in the United States in the 1960s bec...
Use of florfenicol in non‐human primates
Use of florfenicol in non‐human primates
Abstract: Studies were undertaken to determine if florfenicol, an antimicrobial agent structurally similar to chloramphenicol, could be used as an effective broad spectrum antibio...
The Burden of Road Traffic Injuries: A Global Perspective
The Burden of Road Traffic Injuries: A Global Perspective
Introduction Road Traffic Injury (RTI) pose a significant health challenge. It represents the eighth leading cause of death globally, prompting the UN to designate 2011-2020 as...
Validation of the method of quantitative determination of florphenicol in muscle samples by the method of immuno-enzyme analysis
Validation of the method of quantitative determination of florphenicol in muscle samples by the method of immuno-enzyme analysis
Introduction. Amphenicols are a group of chemical compounds with antibacterial activity, including chloramphenicol (HAF), thiamphenicol (TAF), florfenicol (FF) and their derivative...